Sarepta Therapeutics, Inc. (SRPT)

21.21 -0.31 (-1.44%) USD  |  NASDAQ  |  Jan 02, 13:52
More

Sarepta Therapeutics Change in Receivables (Quarterly)

Change in Receivables (Quarterly) Chart

View Change in Receivables (Quarterly) for SRPT.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Change in Receivables (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Change in Receivables (Quarterly) Range, Past 5 Years

View Change in Receivables (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Change in Receivables (Quarterly) Benchmarks

View Change in Receivables (Quarterly) Benchmarks
Start Trial
Pfizer Inc. --
Arrowhead Pharmaceuticals, Inc. Upgrade
Amgen, Inc. Upgrade
Bristol Myers Squibb Co. Upgrade
Alnylam Pharmaceuticals, Inc. Upgrade